Total Payments
$78,753
2024 Payments
$41,670
Companies
34
Transactions
617
Medicare Patients
3,871
Medicare Billing
$423,818
Payment Breakdown by Category
Other$51,979 (66.0%)
Food & Beverage$15,099 (19.2%)
Travel$6,764 (8.6%)
Research$4,713 (6.0%)
Education$199.28 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $39,479 | 12 | 50.1% |
| Food and Beverage | $15,099 | 576 | 19.2% |
| Grant | $11,250 | 1 | 14.3% |
| Travel and Lodging | $6,764 | 23 | 8.6% |
| Unspecified | $4,713 | 1 | 6.0% |
| Charitable Contribution | $1,250 | 1 | 1.6% |
| Education | $199.28 | 3 | 0.3% |
Payments by Type
General
$74,041
616 transactions
Research
$4,713
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alnylam Pharmaceuticals Inc. | $38,384 | 75 | $0 (2024) |
| Medtronic Vascular, Inc. | $13,546 | 18 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $7,813 | 33 | $0 (2024) |
| Abbott Laboratories | $5,851 | 198 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $5,381 | 62 | $0 (2024) |
| Ancora Heart, Inc. | $2,492 | 15 | $0 (2024) |
| PFIZER INC. | $693.81 | 31 | $0 (2024) |
| Impulse Dynamics (USA) Inc. | $550.74 | 16 | $0 (2024) |
| CVRx, Inc. | $532.30 | 14 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $501.13 | 26 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $41,670 | 215 | Alnylam Pharmaceuticals Inc. ($30,298) |
| 2023 | $13,138 | 169 | Alnylam Pharmaceuticals Inc. ($7,910) |
| 2022 | $1,960 | 113 | Abbott Laboratories ($588.41) |
| 2021 | $1,435 | 58 | Abbott Laboratories ($787.71) |
| 2020 | $292.87 | 11 | AstraZeneca Pharmaceuticals LP ($140.46) |
| 2019 | $17,000 | 15 | Medtronic Vascular, Inc. ($12,113) |
| 2018 | $777.50 | 12 | Abbott Laboratories ($534.53) |
| 2017 | $2,480 | 24 | Medtronic Vascular, Inc. ($1,385) |
All Payment Transactions
617 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: Heart Failure | ||||||
| 12/23/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/20/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: Heart Failure | ||||||
| 12/20/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Heart Failure | ||||||
| 12/20/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: Heart Failure | ||||||
| 12/19/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/19/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: Heart Failure | ||||||
| 12/18/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $28.84 | General |
| Category: Genetic Disease | ||||||
| 12/16/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Iron Deficiency Anemia | ||||||
| 12/13/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $26.74 | General |
| Category: Genetic Disease | ||||||
| 12/12/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Cardiology | ||||||
| 12/11/2024 | Nuwellis, Inc. | Aquadex Smartflow Console (Device) | Food and Beverage | Cash or cash equivalent | $14.03 | General |
| Category: Cardiology | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $4.03 | General |
| Category: Cardiovascular | ||||||
| 12/06/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Heart Failure | ||||||
| 12/05/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Obesity | ||||||
| 11/27/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $10.02 | General |
| Category: Heart Failure | ||||||
| 11/20/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $30.36 | General |
| Category: Genetic Disease | ||||||
| 11/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Cardio-renal | ||||||
| 11/18/2024 | Recor Medical Inc | PARADISE RENAL DENERVATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $24.81 | General |
| Category: Endovascular | ||||||
| 11/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Cardio-renal | ||||||
| 11/14/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $27.04 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/13/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,380.00 | General |
| Category: Genetic Disease | ||||||
| 11/13/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Travel and Lodging | Cash or cash equivalent | $160.80 | General |
| Category: Genetic Disease | ||||||
| 11/13/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Heart Failure | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RESEARCH RELATED PUBLICATIONS SUPPORT | NOVARTIS PHARMACEUTICALS CORPORATION | $4,713 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,021 | 1,813 | $333,743 | $112,836 |
| 2022 | 20 | 1,286 | 2,321 | $392,530 | $128,018 |
| 2021 | 20 | 1,328 | 2,415 | $446,676 | $149,515 |
| 2020 | 10 | 236 | 410 | $101,791 | $33,449 |
Total Patients
3,871
Total Services
6,959
Medicare Billing
$423,818
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 179 | 270 | $42,633 | $19,212 | 45.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 88 | 150 | $33,414 | $16,386 | 49.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 82 | 213 | $31,737 | $12,884 | 40.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 33 | 72 | $40,680 | $11,866 | 29.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 46 | 112 | $23,988 | $10,030 | 41.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 152 | 180 | $32,040 | $8,992 | 28.1% |
| 93750 | Evaluation of lower heart chamber assist device | Facility | 2023 | 35 | 198 | $18,810 | $5,993 | 31.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 52 | 54 | $11,772 | $4,690 | 39.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 25 | 25 | $8,331 | $3,478 | 41.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 24 | 26 | $10,582 | $3,372 | 31.9% |
| 93264 | Remote monitoring of pulmonary artery pressure sensor, up to 30 days | Facility | 2023 | 63 | 113 | $9,831 | $3,031 | 30.8% |
| 33289 | Insertion of wireless pressure sensor into lung artery through tube with review by radiologist | Facility | 2023 | 11 | 11 | $12,133 | $2,747 | 22.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 28 | 28 | $7,756 | $2,709 | 34.9% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2023 | 24 | 24 | $29,304 | $2,356 | 8.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 19 | 19 | $4,902 | $1,845 | 37.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 74 | 227 | $8,296 | $1,319 | 15.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 23 | 25 | $2,620 | $1,220 | 46.6% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 23 | 24 | $2,400 | $461.04 | 19.2% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 15 | 15 | $1,305 | $143.40 | 11.0% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 11 | 12 | $504.00 | $66.00 | 13.1% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 14 | 15 | $705.00 | $35.85 | 5.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 206 | 321 | $50,076 | $23,014 | 46.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 36 | 85 | $48,025 | $14,315 | 29.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 112 | 257 | $38,293 | $13,883 | 36.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 52 | 161 | $34,454 | $12,551 | 36.4% |
About Dr. James Ampadu, M.D
Dr. James Ampadu, M.D is a Cardiovascular Disease healthcare provider based in Columbia, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/22/2013. The National Provider Identifier (NPI) number assigned to this provider is 1689916157.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Ampadu, M.D has received a total of $78,753 in payments from pharmaceutical and medical device companies, with $41,670 received in 2024. These payments were reported across 617 transactions from 34 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($39,479).
As a Medicare-enrolled provider, Ampadu has provided services to 3,871 Medicare beneficiaries, totaling 6,959 services with total Medicare billing of $423,818. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Student in an Organized Health Care Education/Training Program, Advanced Heart Failure and Transplant Cardiology
- Location Columbia, SC
- Active Since 03/22/2013
- Last Updated 03/11/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1689916157
Products in Payments
- AMVUTTRA (Drug) $31,589
- HeartWare HVAD (Device) $11,437
- WAINUA (Drug) $7,373
- ENTRESTO (Drug) $5,198
- AccuCinch (Device) $2,492
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $1,940
- CARDIOMEMS (Device) $1,380
- ONPATTRO (Drug) $844.79
- VYNDAQEL (Drug) $638.31
- Barostim Neo System (Device) $532.30
- ICDs (Device) $423.88
- JARDIANCE (Drug) $368.38
- LifeVest (Device) $349.21
- VERQUVO (Drug) $332.82
- FARXIGA (Drug) $329.44
- OPTIMIZER (Device) $309.18
- CardioMEMS HF System (Device) $298.51
- UPTRAVI (Drug) $255.56
- OPSUMIT (Drug) $245.57
- Optimizer (Device) $241.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Columbia
Dr. Patrick Mccann, M.d, M.D
Cardiovascular Disease — Payments: $687,373
Cardiovascular Disease $687,373
Dr. James Fairlamb, M.d, M.D
Cardiovascular Disease — Payments: $450,127
Cardiovascular Disease $450,127
Taishi Hirai, Md, MD
Cardiovascular Disease — Payments: $164,143
Cardiovascular Disease $164,143
Dr. Sultan Siddique, M.d, M.D
Cardiovascular Disease — Payments: $123,448
Cardiovascular Disease $123,448
Michael Cryer, M.d, M.D
Cardiovascular Disease — Payments: $75,074
Cardiovascular Disease $75,074
Venkateshwar Gottipaty, Md, Phd, MD, PHD
Cardiovascular Disease — Payments: $73,338
Cardiovascular Disease $73,338